# US 2025/0144126 A1 · Application of 5'-monophosphate nucleotide and mixture thereof in preparation of drug or food for improving mitochondrial function

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0144126 A1
- Document ID: US20250144126A1
- Status: Published application
- Kind: A1
- Application number: 18/291,328
- Filed: 2022-06-10
- Published: 2025-05-08
- Earliest claimed: 2021-07-27
- Assignees: Yusong CHEN
- Inventors: Yong LI; Na ZHU; Meihong XU; Yusong CHEN
- Web page: https://patentgrep.com/patent/US20250144126A1

## CPC

- A61K 31/7076: containing purines, e.g. adenosine, adenylic acid
- A23L 33/10: using additives (addition of substantially indigestible substances A23L33/21)
- A23L 33/13: Nucleic acids or derivatives thereof (A23L33/145 takes precedence)
- A61K 31/7072: having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
- A61P 39/06: Free radical scavengers or antioxidants
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

5′-monophosphate nucleotide and a mixture thereof are used in preparation of a drug or food for improving a mitochondrial function. 5′-Monophosphate nucleotide is a mixture of a 5′-adenosine monophosphate and 5′-disodium uridine which are produced by means of enzymatic degradation of a ribonucleic acid as a raw material and has a purity of 99% or more. The 5′ nucleotide mixture contains: 23-78% of CMP, 6-44% of AMP, 7-40% of UMP, 7-51% of GMP, and IMP being 0, or greater than 0 and not higher than 2.5%. It has been found 5′-monophosphate nucleotide and the mixture thereof can improve the mitochondrial function of H2O2-induced senescence fibroblasts.

## Claims

### Claim 1

A drug or food item for improving mitochondrial function comprising 5′-monophosphate nucleotide, wherein the 5′-monophosphate nucleotide is 5′-adenosine monophosphate or 5′-disodium uridine.

### Claim 2

A drug or food item for improving mitochondrial function, comprising a 5′-monophosphate nucleotide, wherein the nucleotide mixture comprises four or five 5′ mononucleotides or sodium salts thereof, and mass percentages of the various nucleotides calculated according to forms of CMP, AMP, UPMP, GMP, IMP are respectively as follows: 23-78% of CMP, 6-44% of AMP, 7 -40% of UMP, 7-51% of GMP, and IMP being 0 or greater than 0 and not greater than 2.5%.

### Claim 3 (depends on 1)

The drug or food item according to claim 1, wherein each of the 5′-adenosine monophosphate and 5′-disodium uridine is produced by means of enzymatic degradation of a ribonucleic acid as a raw material and has a purity of more than 99%.

### Claim 4 (depends on 2)

The drug or food item according to claim 2, wherein mass percentages of the various nucleotides calculated according to forms of CMP, AMP, UPMP, GMP, IMP are respectively as follows: 25.80% of CMP, 22.80% of AMP, 20.40% of UMP, 30.20% of GMP and 0.8% of IMP.

### Claim 5 (depends on 1)

The drug according to claim 1, wherein the drug is in the forms of powders, tablets, soft capsules, hard capsules, or oral liquids.

### Claim 6 (depends on 1)

The food item according to claim 1, wherein the food item is in the forms of powders or liquid beverages, preferably in the forms of milk powders, dairy products, or bakery products.

### Claim 7 (depends on 1)

The drug or food item according to claim 1, wherein the 5′-monophosphate nucleotide and mixture thereof improve a basal respiration, a maximum respiratory value, an ATP production capability, and a respiratory reserve of the mitochondria of H2O2-induced senescent cells.

### Claim 8 (depends on 2)

The drug according to claim 2, wherein the drug is in the forms of powders, tablets, soft capsules, hard capsules, or oral liquids.

### Claim 9 (depends on 2)

The food item according to claim 2, wherein the food item is in the forms of powders or liquid beverages, preferably in the forms of milk powders, dairy products, or bakery products.
